Reed Smith LLP

Food and Drug Law Journal

Considering Modifications to Existing Regulatory Incentives to Achieve Greater Racial and Ethnic Diversity in Pivotal Clinical Trials for Drug Approvals

Subscribe
Page d'accueil Perspectives Considering Modifications to Existing Regulatory Incentives to Achieve Greater Racial and Ethnic Diversity in Pivotal Clinical Trials for Drug Approvals

Auteurs: Sarah Thompson Schick Kirsten Axelsen